Table 2:

Treatment-related Grade ≥ 2 Adverse Events

Toxicity	Grade 2 N (%)	Grade 3 N (%)
Neutropenia	2 (7.4)	1 (3.7)
Thrombocytopenia	7 (25.9)	3 (11.1)
Leukopenia/lymphopenia	7 (25.9)	3 (11.1)
White blood cell decreased	6 (22.2)	1 (3.7)
Anemia	1 (3.7)
Diarrhea	4 (14.8)	5 (18.5)
Nausea	6 (22.2)
Vomiting	2 (7.4)
Flatulence	1 (3.7)
Gastroesophageal reflux disease	1 (3.7)
Dysgeusia	1 (3.7)
Dyspepsia	2 (7.4)
Alanine aminotransferase increase	1 (3.7)
Hypoalbuminemia	1 (3.7)
Hyponatremia		1 (3.7)
Hypocalcemia		1 (3.7)
Hypophosphatemia		1 (3.7)
Allergic reaction	1 (3.7)
Rash maculo-papular	1 (3.7)
Rash pustular	1 (3.7)
Dehydration	1 (3.7)
Dizziness	1 (3.7)
Dry skin	2 (7.4)
Paronychia	1 (3.7)
Electrocardiogram QT corrected interval prolonged		1 (3.7)
Fatigue	6 (22.2)	1 (3.7)
Generalized muscle weakness		1 (3.7)
Pleural effusion	1 (3.7)
Vaginal hemorrhage	1 (3.7)
Weight loss	1 (3.7)